Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer

NCT00116155 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cell Genesys